ClinicalTrials.Veeva

Menu
M

MD First Research | Chandler, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dihydroergotamine
Ofatumumab
Zavegepant
AVP-786

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Enrolling
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early in the course of...

Active, not recruiting
Relapse Remitting Multiple Sclerosis
Drug: Ofatumumab

Trial sponsors

C
Novartis logo
Otsuka logo
Pfizer logo
S
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems